Phan Dillon
Technik-/Wissenschafts-/F&E-Leiter bei IBIO, INC.
Aktive Positionen von Phan Dillon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
IBIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Phan Dillon
Ehemalige bekannte Positionen von Phan Dillon
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
PFENEX INC. | Corporate Officer/Principal | - | - |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | - | - |
Ausbildung von Phan Dillon
The University of Texas at Austin | Doctorate Degree |
University of California, Davis | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Doctorate Degree | 2 |
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
IBIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |
- Börse
- Insiders
- Phan Dillon
- Erfahrung